Trial
NCT05560282
Fenfluramine for Adult Dravet Patients
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University Health Network, Toronto
Collaborators
Zogenix, Inc.
Condition
Dravet Syndrome
Intervention
Fenfluramine
Why stopped
Study recruitment was too slow, not enough funds to sustain it.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-05